NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Mild Cognitive Impairment, Mild Dementia, Parkinson Disease, Lewy Body Disease
In brief
A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia
Key facts
- Study ID
- NCT04148391
- Run by
- Aptinyx
- People needed
- 99
- Starts
- 2019-11-14
- Expected to finish
- 2022-12-30
- Last updated by the study team
- 2022-10-27
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Informed Consent
- Diagnosis of Parkinson's disease and mild cognitive impairment or mild dementia OR diagnosis of mild cognitive impairment or mild dementia with Lewy bodies
- Presence of subjective cognitive complaints by the patient
- Verifiable impairment, as defined a CGI-S (Clinical Global Impression-Severity) score of at least 3 (mildly ill).
- Score on the MoCA (Montreal Cognitive Assessment) between 15 and 25, inclusive.
- Stable anti-parkinsonian regimen (if applicable)
- Has a study partner who can accompany the subject at specified study visits
You may not qualify if…
- Clinically meaningful motor complications
- Current use of medications with primarily central nervous system activities
- Other clinically significant medical histories that may interfere with completing the study.
Where it is running
- Aptinyx Clinical Site — Scottsdale, Arizona, United States
- Aptinyx Clinical Site — Fresno, California, United States
- Aptinyx Clinical Site — Simi Valley, California, United States
- Aptinyx Clinical Site — Boca Raton, Florida, United States
- Aptinyx Clinical Site — Bradenton, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — Miami, Florida, United States
- Aptinyx Clinical Site — Miami Lakes, Florida, United States
- Aptinyx Clinical Site — Orlando, Florida, United States
- Aptinyx Clinical Site — Port Charlotte, Florida, United States
- Aptinyx Clinical Site — Port Orange, Florida, United States
- Aptinyx Clinical Site — Sunrise, Florida, United States
- Aptinyx Clinical Site — Decatur, Georgia, United States
- Aptinyx Clinical Site — Farmington Hills, Michigan, United States
- Aptinyx Clinical Site — Golden Valley, Minnesota, United States
- Aptinyx Clinical Site — Toms River, New Jersey, United States
- Aptinyx Clinical Site — Poughkeepsie, New York, United States
- Aptinyx Clinical Site — Asheville, North Carolina, United States
- Aptinyx Clinical Site — Dayton, Ohio, United States
- Aptinyx Clinical Site — Tulsa, Oklahoma, United States
- Aptinyx Clinical Site — Round Rock, Texas, United States
- Aptinyx Clinical Site — Sugar Land, Texas, United States
- Aptinyx Clinical Site — Bellevue, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.